MedTrace Logo

Modulation of Reinforcement Learning

NCT01712464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-05-01

No results posted yet for this study

Summary

This study aims to examine the modulation of neuronal and behavioural parameters of social reinforcement learning.

Conditions

  • Impact of Oxytocin on Social Learning

Interventions

DRUG

Oxytocin vs. Placebo

FMRI measurement and blood examinations after 26 IU Oxytocin (Syntocinon)or placebo on two consecutive days

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Martin Schulte-Rüther, Dr. rer. nat · University Hospital, Aachen

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-18
Primary Completion
2016-08-07
Completion
2016-08-07

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01712464 on ClinicalTrials.gov